Warning: Attempt to read property "ID" on null in /data/sites/web/mobula-igmcom/www/wp-content/plugins/elementor/core/base/document.php on line 356

Warning: Attempt to read property "ID" on null in /data/sites/web/mobula-igmcom/www/wp-content/plugins/elementor/core/base/document.php on line 356
Indocyanine Green (ICG) is officially approved for Sentinel Lymph Node Biopsy (SLNB) in breast cancer - Mobula

Indocyanine Green (ICG) is officially approved for Sentinel Lymph Node Biopsy (SLNB) in breast cancer

๐—” ๐—บ๐—ถ๐—น๐—ฒ๐˜€๐˜๐—ผ๐—ป๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—ณ๐—น๐˜‚๐—ผ๐—ฟ๐—ฒ๐˜€๐—ฐ๐—ฒ๐—ป๐—ฐ๐—ฒ-๐—ด๐˜‚๐—ถ๐—ฑ๐—ฒ๐—ฑ ๐—ฏ๐—ฟ๐—ฒ๐—ฎ๐˜€๐˜ ๐˜€๐˜‚๐—ฟ๐—ด๐—ฒ๐—ฟ๐˜†! ๐Ÿ’š

๐—œ๐—ป๐—ฑ๐—ผ๐—ฐ๐˜†๐—ฎ๐—ป๐—ถ๐—ป๐—ฒ ๐—š๐—ฟ๐—ฒ๐—ฒ๐—ป (๐—œ๐—–๐—š) ๐—ต๐—ฎ๐˜€ ๐—ป๐—ผ๐˜„ ๐—ผ๐—ณ๐—ณ๐—ถ๐—ฐ๐—ถ๐—ฎ๐—น๐—น๐˜† ๐—ฏ๐—ฒ๐—ฒ๐—ป ๐—ฎ๐—ฝ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ฒ๐—ฑ ๐—ฎ๐˜€ ๐˜๐—ฟ๐—ฎ๐—ฐ๐—ฒ๐—ฟ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ฒ๐—ป๐˜๐—ถ๐—ป๐—ฒ๐—น ๐—Ÿ๐˜†๐—บ๐—ฝ๐—ต ๐—ก๐—ผ๐—ฑ๐—ฒ ๐—•๐—ถ๐—ผ๐—ฝ๐˜€๐˜† (๐—ฆ๐—Ÿ๐—ก๐—•) ๐—ถ๐—ป ๐—ฏ๐—ฟ๐—ฒ๐—ฎ๐˜€๐˜ ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—ฎ๐—ฐ๐—ฟ๐—ผ๐˜€๐˜€ ๐—บ๐—ผ๐˜€๐˜ ๐—ผ๐—ณ ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ.

Verdye (Indocyanine Green, ICG) has previously been approved for the breast SLN indication in Spain. Now this is extended to Austria, Belgium, Croatia, Czechia, Denmark, Finland, Greece, Hungary, Ireland, Italy, Netherlands, Poland, Portugal, Romania, Slovenia, Sweden and the UK.

This marks a major step forward for the clinical use of fluorescence-guided surgery.

๐Ÿ” ๐—ช๐—ต๐—ฎ๐˜ ๐—ฑ๐—ผ๐—ฒ๐˜€ ๐˜๐—ต๐—ถ๐˜€ ๐—บ๐—ฒ๐—ฎ๐—ป ๐—ณ๐—ผ๐—ฟ ๐˜€๐˜‚๐—ฟ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ฒ๐—ฎ๐—บ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐˜๐—ต๐—ฒ๐—ถ๐—ฟ ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€?

Where SLNB used to rely on radioactive tracers and blue dye, there is now a validated, patient-friendly alternative that fits into daily surgical practice.

Using 99mTc is a significant burden for both patients as well as hospitals which includes logistical challenges associated with pre-procedure administration and the risk of exposure to ionizing radiation. Additionally, blue dyes can pose significant potential risks including soft tissue necrosis, metabolic and hematologic side effects, making it infrequently utilised for routine surgical care.

With ICG fluorescence, SLNB becomes not just precise but also safer, more streamlined and more sustainable:

This goes beyond a regulatory update. It reflects the growing evidence for ICG as a safe and practical choice that simplifies workflows and improves the patient experience.

The approval was supported by multiple meta-analyses studies which concluded that

  • ICG-fluorescence (ICG-F) is superior to Blue Dye (BD)
  • ICG-F is non-inferior to both radioisotope (RI)ย 
  • ICG-F is superior to both RI and RI+BDย 

๐Ÿ”— Read the full press release by Diagnostic Green here.โ€‹

๐—ช๐—ฒ ๐—ฎ๐—ฟ๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜๐—ผ ๐˜€๐˜๐—ฎ๐—ป๐—ฑ ๐—ฎ๐—น๐—ผ๐—ป๐—ด๐˜€๐—ถ๐—ฑ๐—ฒ ๐˜๐—ต๐—ฒ ๐˜€๐˜‚๐—ฟ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ฒ๐—ฎ๐—บ๐˜€ ๐—ฎ๐—น๐—ฟ๐—ฒ๐—ฎ๐—ฑ๐˜† ๐—น๐—ฒ๐—ฎ๐—ฑ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ถ๐˜€ ๐˜๐—ฟ๐—ฎ๐—ป๐˜€๐—ถ๐˜๐—ถ๐—ผ๐—ป.

Their work is shaping the future of breast cancer surgery. Mobula continues to support surgical teams through each stage, from education to clinical adoption.ย 

More and more hospitals are turning to fluorescence-guided SLNB as an efficient, and patient-friendly alternative to the traditional standard. Mobula supports this shift by offering a certified online training module on SLNB with ICG, developed in collaboration with the team of Annemiek Doeksen from St. Antonius Hospital and the GreenLight group of the LUMC.

Ready to get started? Our e-learning ‘Fluorescence-Guided Sentinel Lymph Node Biopsy’ is live.
๐Ÿ‘‡ Curious what to expect? Watch the short preview video below and take your first step into fluorescence-guided surgery.

๐Ÿ‘‰ Exploreย Mobula Academy training programme, or get in touch for tailored support.

Keep an eye on our website and LinkedIn to stay up to date about these exciting insights and innovations!

Picture of Nanne Duijnkerke

Nanne Duijnkerke

As Manager of Training and Marketing, Nanne Duijnkerke is committed to equipping practitioners with comprehensive training, empowering them to master Fluorescence-Guided Surgery (FGS) and seamlessly integrate it into their daily practice. With her energy, collaborative spirit, and dedication to share expertise, she ensures FGS becomes part of every surgeonโ€™s toolbox.
Advies delen met anderen

Table of contents

ICG approved for SLNB in breast cancer